Obesity ETFs to Gain as Novo's CagriSema Shows 25% Weight LossZacks Investment Research · 5 days ago
Bet on This New GLP-1 ETF to Gain Exposure to a Booming MarketZacks Investment Research · 5 days ago
Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Stock Price Down 0.6% – Time to Sell?Defense World · Oct 15, 2026
From Laggard to Leader: The Surprising Comeback of HealthcareETF Trends · Oct 13, 2026
Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to WinZacks Investment Research · Oct 1, 2026
Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Shares Down 0.4% – Time to Sell?Defense World · Aug 12, 2026Roundhill considers weight loss medications, particularly GLP-1 agonists, to be among the most groundbreaking innovations currently reshaping the global pharmaceutical landscape. This conviction underpins the Roundhill GLP-1 & Weight Loss ETF (OZEM), which is distinguished as the world's inaugural ETF exclusively focused on the GLP-1 and broader weight management sector. Notably, OZEM employs an active management approach.